Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralph Saber

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
A Classification-Based Blood-Brain Barrier Model: A Comparative ApproachRalph Saber, Sandy Rihana
NPJ Precision Oncology|January 9, 2026
Multi-omics fusion network for prediction of early recurrence in colorectal liver metastasesRalph Saber, Mayra Carneiro, Emmanuel Montagnon, et al.
Journal of Translational Medicine|July 27, 2023
Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastasesRalph Saber, David Henault, Nouredin Messaoudi, et al.
Cancers|February 27, 2026
Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung CancerRalph Saber, Marion Tonneau, Olivier Salko, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
A Classification-Based Blood-Brain Barrier Model: A Comparative ApproachRalph Saber, Sandy Rihana
NPJ Precision Oncology|January 9, 2026
Multi-omics fusion network for prediction of early recurrence in colorectal liver metastasesRalph Saber, Mayra Carneiro, Emmanuel Montagnon, et al.
Journal of Translational Medicine|July 27, 2023
Radiomics using computed tomography to predict CD73 expression and prognosis of colorectal cancer liver metastasesRalph Saber, David Henault, Nouredin Messaoudi, et al.
Cancers|February 27, 2026
Multi-Institutional CT Scan-Based Radiomics for Predicting Tumor PD-L1 Expression in Patients with Advanced and Limited Non-Small Cell Lung CancerRalph Saber, Marion Tonneau, Olivier Salko, et al.
Pageof 1